Unlocking the Power of Novel HER3-Targeting Agents in NSCLC and Breast Cancer: Expert Insights and Considerations for Precision Care

Read a Call to Action commentary, view CME-certified microlearning text modules, download slidesets, and listen to a podcast conversation on HER3, a novel therapeutic target under investigation in multiple solid tumor types, from an expert panel including specialists in breast and lung cancers.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.